
1.1 million Americans live with HIV-here’s how you can help.
How pharmacists can help students get the treatments they need.
Information is a patient’s greatest ally, but it’s no help if they can’t understand it.
Drug Topics recently spoke with the FDA about the role pharmacists can play in patient education.
The EpiPen shortage is putting lives at risk and creating a back-up at some pharmacies. But solutions are on the horizon.
The annual report on generic access and savings shows some impressive numbers for 2017.
The latest New Drug Review covers Amgen’s migraine medication.
What the experts have to say about recent shifts in pharmacy law and practice.
Our annual look at the best states to practice pharmacy, based on everything from salary to robbery statistics.
Small Doses is back, bringing you the pharmacy news you need in a way that works for you.
Turns out running a bar shares many similarities with running a pharmacy-but the mistakes cost a lot more.
How new technologies are enabling pharmacies to increase adherence and their bottom line.
The drug is the first approved under the agency's new, quicker generic approval designation.
Interested in cardiology? Here’s why you should consider becoming extra training and certification.
It’s time to fix the disconnect between what students are taught and what’s needed to practice.
If you’ve never thought about becoming certified, now is a great time to do it.
Our latest New Drug Review covers Dova’s most recent medication.